Exclusive: 'Conflict minerals' the latest trap for medtech
This article was originally published in SRA
Executive Summary
First it was "blood diamonds", now it’s "blood minerals" and medtech companies should be worried. A controversial US rule that requires companies to disclose their use of "conflict minerals" is set to trigger a whole new type of compliance headaches for the industry1-3.